Granza Bio (YC Winter 2024)

TL;DR: Granza Bio is a Y Combinator Winter 2024 startup Reprogramming Immunity for Target-Specific Medicines, currently active with a team of 7.

Reprogramming Immunity for Target-Specific Medicines

YC ID
29485
YC Batch
Winter 2024
Status
Active
Team size
7
Industry
Healthcare, Therapeutics
Tags
Synthetic Biology, Biotech, Healthcare
YC profile
https://www.ycombinator.com/companies/granza-bio

Last verified:

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.

Built by LemStudio

Building or buying SaaS? Try our founder tools →

Frequently asked questions

Is Granza Bio a YC (Y Combinator) company?

Yes. Granza Bio was funded by Y Combinator in the Winter 2024 batch. Reprogramming Immunity for Target-Specific Medicines

What does Granza Bio do?

Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed…

What YC batch was Granza Bio in?

Granza Bio was part of Y Combinator's Winter 2024 batch.

How big is Granza Bio?

Granza Bio has a team of 7 people according to Y Combinator's directory.

Is Granza Bio still active?

Granza Bio is currently listed as Active with a team of 7 in Y Combinator's directory.

More YC Winter 2024 companies

More Healthcare YC startups

Explore related YC hubs

Loading interactive view…